NCT01677455 · Interventional trial
An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer
Overall registry status Completed
Phase 2
Conditions Breast Cancer, ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer
Delaware Valley sites
- Synta Pharmaceuticals Investigative Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory